Associations Between Myeloid-Derived Suppressor Cells, TIM-3+ T Cells, and Clinical Factors During the Post-transplant Neutropenia Period in Patients With Multiple Myeloma
Following autologous hematopoietic stem cell transplantation (HSCT), cellular interactions and the possible impact of therapeutic interventions on the immune recovery have not been fully investigated and may be of interest as predictive biomarkers and targets for novel therapies.
Authors
- Е. В. Баторов (ORCID: https://orcid.org/0000-0003-2902-9336)
- Galina Ushakova
- E. R. Chernykh
- Т. В. Тыринова (ORCID: https://orcid.org/0000-0002-7987-2017)
- С. А. Сизикова (ORCID: https://orcid.org/0000-0001-7109-3839)
- Aleksandr Ostanin
- Vera Denisova
- Dariya S. Batorova
- Tatyana Aristova
Institutions
- Novosibirsk State University (RU)
- Research Institute of Fundamental and Clinical Immunology (RU)
Publication Details
- Journal
- Cureus
- Published
- 2025-06-24
- DOI
- https://doi.org/10.7759/cureus.86641
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00